PART1 and central nervous system cancer: lncRNA PART1 was reported to be significantly downregulated in glioma tissues and cell lines, and in the same study, PART1 promoted apoptosis and inhibited the proliferation of glioma cells by sponging miR-190a-3p, and subsequently upregulating PTEN and inactivating Akt signaling [57].